Peptide Therapy Among the most exciting developments in the functional medicine approach to long COVID is the emerging role of therapeutic peptidesand the early clinical results of several compounds are compelling
Absence of COA documentation or refusal to provide testing results raises obvious concerns
Patients struggling with neuroautoimmune conditions often exhibit multisystem symptoms, including gastrointestinal issues, chemical sensitivities, anxiety, insomnia, and heightened reactivity to supplements or medications, hallmarks that overlap significantly with mast cell activation syndrome (MCAS)
Q3: How is the KLOW peptide blend dosed in research planning
KPV is generally discussed as an immune-modulating or anti-inflammatory research peptide rather than a broad immunosuppressant
It influences several overlapping repair pathways simultaneously: it may promote new blood vessel growth (VEGF), modulate the nitric oxide system, support collagen synthesis, and protect gut mucosal tissue
